ISCIENCE 润色咨询

iScience

出版年份：暂无数据 年文章数：3724 投稿命中率： 开通期刊会员，数据随心看

出版周期：M 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2024-10-25 1482b61bm01暂无昵称 来自福建省

    7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收

    12

    展开12条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2025-02-26 ms3000000851999119 来自法国

    投稿命中率:95.0
    偏重的研究方向：医学综合
    经验分享：cell子刊，文章质量有保证

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2024-05-09 ms2000000185262432 来自广西

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤;蛋白组
    经验分享：2024年2月16投稿
    2024年3月18小修
    2024年3月29修回，等得都想催稿了
    2024年4月24原则性接收，开始改格式，改了三四次格式
    2024年5月09接收
    感谢iscience的认可，兄弟们加油

    8

    展开8条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2023-01-27 1250d11bm60(暂无昵称) 来自浙江省

    有幸发表2篇，感觉编辑很nice

    6

    展开6条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2025-01-07 ms2000000658865901 来自广东省

    请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2024-10-16 ms3000001892618058 来自湖北省

    二审两个多月了，还没消息，有一样的小伙伴吗？

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2024-03-09 ms3000000526945160 来自湖北省

    偏重的研究方向：分子生物学
    经验分享：想问下with editor 10多天了正常吗

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2024-03-09 ms3000000526945160 来自湖北省

    偏重的研究方向：分子生物学
    经验分享：有人with editor已经2周了吗？等着毕业焦虑

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2024-06-05 ms2000001471285364 来自湖北省

    大家under review多久呀？现在一个月了还没有消息

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2233162, encodeId=f9fc2233162c0, content=7.14 Cell-Press Multi-Journal 投稿(选了Cell Reports和iScience) 7.24 Cell reports拒了，iScience 可以送审，所以当天转投iScience 7.28 送审 8.27 一审意见返回 major revision 10.2 修回 10.15 一审结束 accepted-in-principle 开始改格式 10.15-10.25 从R1改格式改到R5 编辑效率感人！ 10.25 正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57a5273929, createdName=1482b61bm01暂无昵称, createdTime=Fri Oct 25 18:53:29 CST 2024, time=2024-10-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2253623, encodeId=507b225362327, content=投稿命中率:95.0<br>偏重的研究方向：医学综合<br>经验分享：cell子刊，文章质量有保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Wed Feb 26 03:39:21 CST 2025, time=2025-02-26, status=1, ipAttribution=法国), GetPortalCommentsPageByObjectIdResponse(id=2203734, encodeId=33412203e34f5, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤;蛋白组<br>经验分享：2024年2月16投稿<br>2024年3月18小修<br>2024年3月29修回，等得都想催稿了<br>2024年4月24原则性接收，开始改格式，改了三四次格式<br>2024年5月09接收<br>感谢iscience的认可，兄弟们加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Thu May 09 20:56:44 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2111647, encodeId=abe2211164e65, content=有幸发表2篇，感觉编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Fri Jan 27 16:03:33 CST 2023, time=2023-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2246963, encodeId=a7b422469639e, content=请问给位大佬版面费什么时候交？我的online了，但还没让交版面费呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Tue Jan 07 14:03:10 CST 2025, time=2025-01-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2231251, encodeId=7c1722312512e, content=二审两个多月了，还没消息，有一样的小伙伴吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=522b9253477, createdName=ms3000001892618058, createdTime=Wed Oct 16 22:35:58 CST 2024, time=2024-10-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学<br>经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2192191, encodeId=ebf521921918e, content=偏重的研究方向：分子生物学<br>经验分享：有人with editor已经2周了吗？等着毕业焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 06:55:43 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2208443, encodeId=ab392208443ef, content=大家under review多久呀？现在一个月了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Wed Jun 05 14:43:36 CST 2024, time=2024-06-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2240383, encodeId=fda82240383df, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：流批, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbaa9556830, createdName=ms7000001053510494, createdTime=Mon Dec 02 14:00:26 CST 2024, time=2024-12-02, status=1, ipAttribution=广东省)]
    2024-12-02 ms7000001053510494 来自广东省

    审稿速度:24.0 | 投稿命中率:5.0
    经验分享：流批

    0

共366条页码: 1/37页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分